Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promotora-led weight loss intervention in Latinas at-risk for diabetes
NCT02088034Phase 4
Key facts
- Status
- Completed
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Countries
- 1
- Sponsor
- Temple University
- Modality
- Small Molecules
- Drugs
- metformin
- Conditions
- type 2 diabetes mellitus (T2DM)
01
Overview
Phase 4, randomised, open-label trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Temple University. Primary endpoint: Body Weight at 1 year. Started Sep 2013; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Latinas aged 20+ with BMI >= 25 and increased risk of diabetes (A1C 5.6-6.4% and ADA score >= 4).
04
Endpoints
Primary
Body Weight
Beyond the preview
Go deeper on NCT02088034.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088034.